Why the study?
Does tricuspid leaflet augmentation combined with annuloplasty improve clinical and echocardiographic outcomes in patients with severe functional tricuspid regurgitation and severe leaflet tethering?
Does tricuspid leaflet augmentation combined with annuloplasty improve clinical and echocardiographic outcomes in patients with severe functional tricuspid regurgitation and severe leaflet tethering?
Tricuspid leaflet augmentation combined with annuloplasty is feasible and provides excellent mid-term clinical and echocardiographic outcomes for severe functional tricuspid regurgitation with severe tethering.
May warrant consideration for severe tethering; leaves open need for RCTs to confirm durability versus annuloplasty alone.
OBJECTIVES: Functional tricuspid regurgitation (FTR) is usually managed surgically using various types of annuloplasty. FTR has been reported to recur in up to 45% of patients, with severe leaflet tethering being an important risk factor for recurrence. The aim of this study is to report the clinical and echocardiographic mid-term results after leaflet augmentation in patients with FTR due to severe leaflet tethering. METHODS: From May 2008 to July 2014, 22 patients were found to have a severe FTR with a tethering height of at least 8 mm; all of them underwent leaflet augmentation: the anterior and part of the posterior leaflet were detached from the anterior annulus; a patch of fresh autologous pericardium was used to generously fill the gap between the anterior annulus and the detached leaflet. A 5/0 Pronova suture locked at every step was used to avoid any purse string effect. In 2 patients, the septal leaflet also needed to be augmented using a comparable technique. In all but one (annular calcification) patient, a semi-rigid ring annuloplasty was added. The mean age was 67.1 ± 13.7 years; it was a redo procedure in 12 cases (54.5%), 11 patients (50%) had right ventricle failure and 3 (23.1%) had renal failure. RESULTS: The median follow-up was 2.1 ± 1.9 years. Thirty-day and 4-year survival averaged at 81.1 ± 8.5 and 71.6 ± 9.8%, respectively. At 4 years, 84 ± 10.6% of the survivors were in NYHA class I or II and only 2 patients had a TR of ≥2 with a global freedom from TR ≥2 of 85.7 ± 13.2%. There was no reintervention. CONCLUSIONS: Tricuspid leaflet augmentation combined with annuloplasty is feasible and leads to excellent clinical and echocardiographical mid-term results even in the presence of severe leaflet tethering and right ventricular failure.
No takes yet. Share an insight, caveat, or question.
Pettinari et al. (2016) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: